For this study, we examined tumors in three large breast cancer patient cohorts (TCGA, METABRIC and GSE124647) and their MYC targets v1 and MYC targets v2 scores and the correlation with cell proliferation, clinical and pathologic features, survival differences, and immune cell infiltration. Here, MYC is linked to breast carcinoma.